How commercial “agenda laundering” is shaping critical care
In a recent article published in the British Medical Journal https://www.bmj.com/ INI-CRCT patient expert D’Arcy Duquette along with members Dr Khalil Chaibi and Pr Stéphane Gaudry discuss ties with industry, particularly in the field of critical care research, that created biases in the decision making through a process called “agenda laundering”?
They define agenda laundering as a process by which clinical practice is modified little by little overtime by commercial interests influencing scientific work. Over time, the practice becomes common place and the initial commercial interests are no longer visible. This why the term « laundering » is used.
The article describes examples of agenda laundering in the field of critical care including the use of hydroxyethyl starch and albumin as an alternative to saline.
